Subscribe
Search
Close this search box.
Subscribe
Search
Close this search box.
Picture of MEDVIA

MEDVIA

MEDVIA is a spearhead cluster that fosters health innovation by facilitating collaborations between biotech and medtech companies, hospitals, research institutes, and service providers in Flanders and Brussels, providing members with tailored services and funding. Our articles feature MEDVIA members and projects.
Icon-linkedin Icon-x Link
Picture of MEDVIA

MEDVIA

MEDVIA is a spearhead cluster that fosters health innovation by facilitating collaborations between biotech and medtech companies, hospitals, research institutes, and service providers in Flanders and Brussels, providing members with tailored services and funding. Our articles feature MEDVIA members and projects.
Icon-linkedin Icon-x Link

Intelligent dentistry: AI is making surgeries safer

The AIPLANT project aims to reduce complications from dental implant surgery using AI-based preoperative planning. The project is a collaboration between the Centre for Dentomaxillofacial Imaging at UZ Leuven, AI startup Relu, and Xentro Dental. 

Hearts in space: a Belgian story of successful collaboration

AstroCardia has developed a heart-on-a-chip to study cardiovascular aging… in space! Trials will begin in 2025 aboard the International Space Station (ISS). The MEDVIA project was made possible thanks to the combined expertise of the five Belgian partners: Space Applications Services, the Belgian Nuclear Research Center (SCK CEN), QbD Group, BIO INX, and Antleron.

Biodevice-CRO: smart solutions for better bioprocessing

Biodevice-CRO is a MEDVIA project uniting three very different, but complementary, Flemish companies: ICsense, Comate, and Antleron. This unique partnership aims to provide life science actors with customizable, modular bioprocess solutions through a collaborative Contract Research Organization (CRO) model. These smart solutions – the biodevice based on an integrated chip, biofluidic cartridge, and functional device – will enable fast-track development of personalized medicines and improved diagnostics.

OHMX.bio: state-of-the-art omics solutions

OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and epigenetic profiling, as well as companion diagnostics, the company uses second- and third-generation sequencing technology to enable scientific insights and build assays for better drug and therapy development. With both a wet lab and dry lab in house, OHMX.bio offers a full-circle service to biotech and pharma partners.

Byteflies: virtual care solutions for all

Byteflies is on a mission to make virtual care available to all. The Belgian company has developed a platform for remote patient monitoring solutions, to save precious time for healthcare providers, reduce hospitalization costs, and boost the quality of life for patients. The aim is to aid the transition from fragmented to connected healthcare, enabling a continuum of care through virtual solutions.

CoMoveIT: patient-driven mobility solutions for people with complex movement disorders

CoMoveIT is a striking example of how visionary ideas can be turned into life-changing innovations once the right technology becomes available. We spoke with CoMoveIT’s CTO, Sotirios Gakopoulos, about the Belgian company’s unique solution to improve the mobility of patients with complex movement disorders, like cerebral palsy.

Dosing flash radiation for the future of cancer treatment

Flash radiation has the potential to become a revolution in radiation therapy. An incredibly promising cancer treatment that limits the damage to surrounding tissue, it is currently in the pre-clinical stage. MEDVIA-funded project eFlash2D is working to assure that dosing is ready when flash radiation enters clinical trials.

MEDVIA: paving the way for health innovation

There is a lot of money being invested in health innovation in Flanders, yet companies consistently run into the same roadblocks on their path to market. MEDVIA’s mission is to bring people together to address these barriers, and to facilitate the creation of complex collaborations between different members of the ecosystem for truly innovative patient solutions.

Power to the patient: Conference tackles challenges of medtech innovation

How to integrate patient perspectives in innovation

After recovering from metastatic colon cancer, Stefan Gijssels became a patient advocate dedicated to improving the healthcare system that saved his life. As Chair of the Belgian Patient Expert Center (PEC), he has helped to establish a training program turning patients into patient experts who can provide stakeholders like hospitals and companies with valuable insights during the innovation process.

MedTech Flanders becomes part of MEDVIA, Flanders’ healthtech spearhead cluster

Spearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation

Ann Van Gysel appointed CEO of flanders.healthTech

Ghent, Belgium, 20 January 2022 – Dr. Ann Van Gysel has been appointed as CEO of the flanders.healthTech spearhead cluster. She will lead the cluster, which brings together personalized and digital medicine and healthcare technology in Flanders, and supports the development and implementation of new technologies in the Flemish healthcare sector.